Tsukuba, Japan

Eisaku Tsujii


Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 16(Granted Patents)


Location History:

  • Tsubuka, JP (1994)
  • Tsukuba, JP (1990 - 1996)

Company Filing History:


Years Active: 1990-1996

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Eisaku Tsujii

Introduction: Eisaku Tsujii, an esteemed inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals. With a total of nine patents to his name, he is recognized for his innovative approaches in treating various medical conditions.

Latest Patents: Among his latest inventions are two notable patents. The first is the antimicrobial agent, FR109615, which is a method for killing pathogenic fungi by utilizing (1R,2S)-2-aminocyclopentanecarboxylic acid or its salts. The second patent involves WS7622A mono- or di-sulfate, aimed at treating degenerative diseases such as cystic fibrosis, chronic bronchitis, and bronchiectasis through the administration of a therapeutically effective amount of the compound or its pharmaceutically acceptable salts.

Career Highlights: Eisaku Tsujii is currently affiliated with Fujisawa Pharmaceutical Company, Ltd., where he utilizes his expertise to drive innovation in pharmaceutical development. His work has paved the way for new treatment options that aim to improve patient care and outcomes.

Collaborations: Throughout his career, Tsujii has collaborated with notable colleagues such as Masakuni Okuhara and Masanori Okamoto. Together, they have contributed to the advancement of medical science through their combined expertise and innovative ideas.

Conclusion: Eisaku Tsujii stands as a prominent figure in the realm of invention and innovation in pharmaceuticals. His latest patents demonstrate his commitment to tackling complex medical challenges, ultimately enhancing healthcare solutions for patients facing serious health issues. As he continues to work alongside talented colleagues, the impact of his inventions will undoubtedly resonate within the industry for years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…